Patients' Views on Paying to Participate in Clinical Trials.

Area of Science:

• Clinical research ethics
• Patient-centered care

Background:

• Clinical trials are essential but costly, sometimes requiring participants to pay for study drugs.
• Participant costs in trials raise ethical concerns for review boards and researchers.

Purpose of the Study:

• To evaluate patient perspectives on bearing the costs of drugs in clinical trials.
• To understand patient concerns and expectations regarding financial responsibilities in research.

Main Methods:

• Interviewed 33 oncology and cardiology patients using hypothetical trial scenarios involving drug costs.
• Assessed patient reactions, concerns, preferences, and safety-related financial considerations.

Main Results:

• Patients expressed concerns about drug expenses, fairness, and potential exclusion of disadvantaged individuals.
• Despite concerns, patients valued autonomy, supported allowing "pay-to-participate" trials, and cited personal finances as a key factor.

Conclusions:

• The majority of patients support the option to participate in trials with costs, advocating against prohibition.
• Understanding patient financial perspectives is crucial for ethical trial design and review board decisions.